This inventor holds 1 USPTO granted patent. Top assignee: Yuhan Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sewoong Oh: Innovator in Tyrosine Kinase Inhibitors
Introduction
Sewoong Oh is a prominent inventor based in Gyeonggi-Do, South Korea. He has made significant contributions to the field of medical therapies, particularly in the development of targeted cancer treatments.
Latest Patents
Sewoong Oh holds a patent for "Therapies with 3rd Generation EGFR Tyrosine Kinase Inhibitors." This innovative work focuses on improving treatment options for patients with specific types of cancer, showcasing his commitment to advancing medical science. He has 1 patent to his name.
Career Highlights
Sewoong Oh is currently employed at Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable coworkers is Seonmi Kang, with whom he has worked closely on various projects. Their collaboration has been instrumental in driving forward the research and development of innovative therapies.
Conclusion
Sewoong Oh's contributions to the field of medical therapies, particularly through his patent on tyrosine kinase inhibitors, highlight his role as an influential inventor. His work continues to impact the landscape of cancer treatment, making him a key figure in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile